Tzu-tung Kuo
Taipei, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Dipeptidyl peptidase-4 inhibitors are associated with a lower risk of osteoarthritis in patients with type 2 diabetes.
Journal: Therapeutic advances in musculoskeletal disease
Published: September 01, 2025
Impact of drug-drug interaction of JAK inhibitors, CYP enzyme inhibitors and OAT3 inhibitors on persistence and infection rates in patients with autoimmune rheumatic diseases.
Journal: Joint bone spine
Published: August 12, 2025
Holistic needs assessment for hospitalized patients: A cross-sectional study.
Journal: Journal of psychosomatic research
Published: June 21, 2025
Effects of paternal preconception exposure to conventional and biologic DMARDs on newborn outcomes.
Journal: Arthritis research & therapy
Published: March 06, 2025
Severe cutaneous adverse reactions and risk of autoimmune disease, including psoriasis and inflammatory bowel disease: a cohort study.
Journal: Clinical and experimental dermatology
Published: November 01, 2024
Hydroxychloroquine dose-dependently reduces the risk of incident diabetes in primary Sjögren syndrome patients on glucocorticoids: a nationwide population-based cohort study.
Journal: Arthritis research & therapy
Published: October 02, 2024
Psoriasis Risk Is Lower in Type 2 Diabetes Patients Using Dipeptidyl Peptidase-4 Inhibitors or Thiazolidinediones Compared to Sulfonylureas.
Journal: Clinical and translational science
Published: September 10, 2024
Effect of TNF-α blockers on reducing the risk of dementia in rheumatoid arthritis: a nationwide cohort study.
Journal: Clinical and experimental rheumatology
Published: July 26, 2024
Anti-osteoporosis drugs reduce mortality in cancer patients: A national cohort study of elderly with vertebral fractures.
Journal: Annals of the Academy of Medicine, Singapore
Published: June 26, 2024
Maternal Prenatal Infections and Biliary Atresia in Offspring.
Journal: JAMA network open
Published: January 03, 2024
Association of interferon-based therapy with risk of autoimmune diseases in patients with chronic hepatitis C virus infection: A population-based Taiwanese cohort study.
Journal: Frontiers in immunology
Published: July 13, 2022
Last Updated: 09/26/2026